Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare is supported by a highly durable, government-sponsored franchise that serves about 5 million members across 21 states, with more than 85% tied to Medicaid and over half concentrated in California, New York, Texas, and Washington, which gives it scale but also a large, defensible operating base. Its bullish case rests on multiple independent drivers: management’s 2029 framework points to $64B in premium revenue and strong EPS growth, while Medicaid MCR improvement, a conservative 33% win rate on about $90B of pipeline RFPs, and 100–150 bps of AI-driven G&A gains offer meaningful upside. The Duals opportunity is especially compelling because Molina has only 6% share in geographies where it has 16% Medicaid share, suggesting room for structural share gains as integrated enrollment rules favor incumbent Medicaid operators.

Molina Healthcare is exposed to a structurally fragile mix of government-sponsored businesses, with more than 85% of members in Medicaid and over half of enrollees concentrated in California, New York, Texas, and Washington, leaving earnings highly sensitive to state funding decisions and contract renewals. Although 2Q26 adjusted EPS of $1.51 beat estimates, the outlook remains pressured by Marketplace weakness, a 2026 Medicaid rate environment modeled at 4% versus about 5% cost trend, and OBBBA-related membership attrition that could exceed 6%, all of which threaten margin recovery. The company’s $9.00/share embedded earnings backlog is a meaningful asset, but the revision down from more than $11 at the May 2026 Investor Day, plus Florida contract execution risk and a 2025 Medicare MCR of 92.4%, underscores that growth assumptions are still vulnerable to operating and regulatory setbacks.